Study and Modulation of Immune Responses in Primary and Metastatic Colon Cancers

Not yet recruitingOBSERVATIONAL

Enrollment

500

Participants

Timeline

Start Date

June 15, 2024

Primary Completion Date

June 15, 2025

Study Completion Date

June 15, 2039

Conditions

Colon CancerPeritoneal Carcinoma

Interventions

OTHER

Sampling

Blood and surgical specimen sampling the day of surgery

Trial Locations (2)

Hôpital Saint Louis - gastoenterology, Paris

Hôpital Saint Louis - visceral, oncological and endocrine surgery, Paris

All Listed Sponsors

lead

Assistance Publique - Hôpitaux de Paris

OTHER

NCT06435689 - Study and Modulation of Immune Responses in Primary and Metastatic Colon Cancers | Biotech Hunter | Biotech Hunter